What Savara Investors Should Know About This 580,187-Option Exercise and FDA Timeline

This clinical-stage biotech focused on rare lung diseases reported significant insider selling amid a year of strong share gains.

CryptoAlerta — análise de criptomoedas e mercado em tempo real